Suppr超能文献

双花扁豆对糖尿病大鼠血糖和血脂的影响。

Effect of Dolichos biflorus on blood sugar and lipids in diabetic rats.

作者信息

Purwar Brijesh, Saxena Yogesh

机构信息

Department of Physiology, Himalayan Institute of Medical Sciences, Jolly Grant, Dehradun--248 140, India.

出版信息

Indian J Physiol Pharmacol. 2013 Jan-Mar;57(1):63-71.

Abstract

Diabetes mellitus is a chronic disease characterized by hyperglycemia and dyslipidemia, which leads to severe morbid complications. In view of the effectiveness of conventional herbal adjutants the present study was taken to assess the anti-diabetic and anti-lipidemic effect of Dolichos biflorus. 32 healthy albino rats of either sex were randomly divided into 4 equal groups (I-IV) each having 8 rats. Group I, control rats received only vehicular fluid while Group II received only Dolichos biflorus for the experimental period of 30 days. Diabetes was induced in Group II and Group IV rats by single intravenous dose of STZ and confirmed on 3rd day with fasting blood sugar (FBS) more than 250 mg/dl. Group III diabetic rats, received vehicular fluid while Group IV diabetic rats received Dolichos biflorus in single dose of 300 mg/kg body weight/day intra-gastrically up to the experimental period of 30 days. FBS levels were assessed on 1st, 8th, 15th, 22nd and 30th day. On last day overnight fasted rats were sacrificed for drawing the sample for lipid profile from beating heart and harvested for pancreatic tissue histology. Data obtained showed that FBS levels were decreased significantly when Dolichos biflorus was given to diabetic rats from mean +/- SD values 362 +/- 63.36 to 118 +/- 38.55 with p value < 001. S cholesterol and S. triglyceride levels were also decreased significantly with P value < 001. It was concluded that Dolichos biflorus has anti-diabetic and anti-lipidemic effect at daily oral dose and can be used as an adjuvant for management of diabetes mellitus and its associated complications.

摘要

糖尿病是一种以高血糖和血脂异常为特征的慢性疾病,可导致严重的并发症。鉴于传统草药辅助剂的有效性,本研究旨在评估白花菜豆的抗糖尿病和抗血脂作用。将32只健康的白化病大鼠(雌雄不限)随机分为4组(I-IV组),每组8只。I组为对照大鼠,仅接受赋形剂溶液;II组在30天的实验期内仅接受白花菜豆。II组和IV组大鼠通过单次静脉注射链脲佐菌素诱导糖尿病,并在第3天通过空腹血糖(FBS)超过250mg/dl进行确认。III组糖尿病大鼠接受赋形剂溶液,而IV组糖尿病大鼠在30天的实验期内每天以300mg/kg体重的单剂量胃内给予白花菜豆。在第1、8、15、22和30天评估FBS水平。在最后一天,将过夜禁食的大鼠处死,从跳动的心脏采集样本进行血脂分析,并采集胰腺组织进行组织学检查。获得的数据显示,当给糖尿病大鼠服用白花菜豆时,FBS水平从平均±标准差362±63.36显著降至118±38.55,p值<0.01。总胆固醇和甘油三酯水平也显著降低,p值<0.01。得出的结论是,白花菜豆在每日口服剂量下具有抗糖尿病和抗血脂作用,可作为糖尿病及其相关并发症管理的辅助药物。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验